# Abbott Diabetes Care clinical trials: 43 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 43 trials with Abbott Diabetes Care as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Abbott Diabetes Care: 43 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/abbott-diabetes-care

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 43
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 43, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 31, 2026 | NCT07739342 | Evaluating the Occurrence of DKA in People With Type I Diabetes | Abbott Diabetes Care | Observational | Not yet recruiting | Type 1 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739342) |
| April 10, 2025 | NCT06921902 | Glycemic Metrics and Patterns in People With and Without Prediabetes | Abbott Diabetes Care | Observational | Recruiting | Pre Diabetes | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06921902) |
| November 1, 2024 | NCT06668935 | Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring | Abbott Diabetes Care | Observational | Recruiting | Diabetes Mellitus | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06668935) |
| February 20, 2024 | NCT06268821 | Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland | Abbott Diabetes Care | Not applicable | Terminated | Type 2 Diabetes Treated With Insulin | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06268821) |
| February 20, 2024 | NCT06268808 | Initiation of Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin, in Italy | Abbott Diabetes Care | Not applicable | Completed | Type 2 Diabetes Treated With Insulin | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06268808) |
| July 27, 2023 | NCT05962710 | FreeStyle Libre 3 Continuous Glucose Monitoring System | Abbott Diabetes Care | Observational | Terminated | Diabetes Mellitus | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05962710) |
| July 13, 2023 | NCT05944432 | CGM Use in Adults With Type 2 Diabetes on Basal Insulin | Abbott Diabetes Care | Not applicable | Active not recruiting | Diabetes Mellitus, Type 2 | 469 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05944432) |
| February 22, 2022 | NCT05251116 | Study of an Interstitial Fluid Glucose Sensor | Abbott Diabetes Care | Not applicable | Completed | Diabete Mellitus | 332 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05251116) |
| January 13, 2022 | NCT05189938 | HbA1c Variation Study | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 488 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05189938) |
| December 23, 2021 | NCT05168306 | T2 FSL2 Weight Loss | Abbott Diabetes Care | Observational | Terminated | Diabetes Mellitus, Type 2 | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05168306) |
| July 13, 2021 | NCT04959552 | FSL2 Post Approval Study for Pediatric and Young Adults Patients | Abbott Diabetes Care | Observational | Active not recruiting | Diabete Mellitus | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04959552) |
| April 13, 2021 | NCT04843527 | Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes | Abbott Diabetes Care | Not applicable | Unknown | Diabetes Mellitus, Type 2 | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04843527) |
| October 27, 2020 | NCT04604093 | Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 358 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04604093) |
| October 8, 2020 | NCT04577976 | FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG | Abbott Diabetes Care | Observational | Terminated | Diabetes Mellitus | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04577976) |
| July 9, 2020 | NCT04464772 | FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04464772) |
| January 29, 2019 | NCT03820050 | FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03820050) |
| July 31, 2018 | NCT03607448 | Freestyle Libre Flash Glucose Monitoring System | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03607448) |
| April 18, 2018 | NCT03502174 | FreeStyle Libre Glucose Monitoring System in Pediatric Populations | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03502174) |
| February 28, 2018 | NCT03448380 | FreeStyle Libre Flash Glucose Monitoring System Post Approval Study | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 935 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03448380) |
| February 28, 2018 | NCT03448367 | FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients | Abbott Diabetes Care | Observational | Terminated | Diabetes Mellitus | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03448367) |
| February 14, 2018 | NCT03433573 | Paediatric Use of the Abbott Sensor Based Glucose Monitoring System | Abbott Diabetes Care | Not applicable | Completed | Diabetes Mellitus | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03433573) |
| December 12, 2017 | NCT03369899 | FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations | Abbott Diabetes Care | Observational | Completed | Diabete Mellitus | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03369899) |
| August 22, 2017 | NCT03257501 | FreeStyle Libre Flash Accuracy Study | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03257501) |
| May 18, 2017 | NCT03159546 | FreeStyle Libre Flash Glucose Monitoring System Accuracy | Abbott Diabetes Care | Observational | Completed | Diabete Mellitus | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03159546) |
| May 5, 2017 | NCT03141892 | FreeStyle Libre Flash Glucose Monitoring System Accuracy Study | Abbott Diabetes Care | Observational | Completed | Diabetes Mellitus | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03141892) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 4 | 1 |
| Not applicable | 16 |
| Observational | 26 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 32 |
| Terminated | 5 |
| Recruiting | 2 |
| Active not recruiting | 2 |
| Unknown | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus | 30 |
| Diabetes Mellitus, Type 2 | 7 |
| Diabetes Mellitus, Type 1 | 6 |
| Glucose Intolerance | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [T-shirt printers in the United States](https://specstream.ai/data/businesses/t-shirt-printers/united-states)
- [Clinical laboratories in the United States](https://specstream.ai/data/businesses/clinical-laboratories/united-states)
- [Language schools in the United States](https://specstream.ai/data/businesses/language-schools/united-states)
- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Coffee shops in the United States](https://specstream.ai/data/businesses/coffee-shops/united-states)
- [Law schools in the United States](https://specstream.ai/data/businesses/law-schools/united-states)
